Validation of a Virtual Patient and Virtual Trials Method for Accurate Prediction of TGC Protocol Performance F Suhaimi 1,5, A.J. LeCompte 1, S Penning.

Slides:

Advertisements

Similar presentations

University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,

Advertisements

The SPRINT Protocol for Tight Glycaemic Control Geoffrey M Shaw, J. Geoffrey Chase, Xing-Wei Wong, Thomas Lotz, Jessica Lin, Aaron LeCompte, Timothy Lonergan,

A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.

Steady-State Optimal Insulin Infusion for Hyperglycemic ICU Patients J G Chase, G C Wake, Z-H Lam, J-Y Lee, K-S Hwang and G. Shaw University of Canterbury.

Foos et al, EASD, Lisbon, 13 September 2011 Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta- analysis studies Volker.

MODELING METHOD Glucose-Insulin System Model CLINICAL DATA DATA: Are taken from the SPRINT [3] TGC cohort totalling 393 patients and ~40,000 patient hours.

MODELING THE PROGRESSION AND TREATMENT OF HIV Presented by Dwain John, CS Department, Midwestern State University Steven M. Shechter Andrew J. Schaefer.

Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.

The Cost-Effectiveness of Providing DAFNE to Subgroups of Predicted Responders J Kruger 1, A Brennan 1, P Thokala 1, S Heller 2 on behalf of the DAFNE.

Centre Cérébrovasculaire COMORBIDITY ANALYSIS AND 3 MONTHS FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE: DATA FROM ACUTE STROKE REGISTRY AND ANALYSIS.

Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock Dellinger RP, Levy MM, Rhodes A, Annane D, Carcillo JA, Gerlach H,

Diabetes control: a complexity perspective Dr Tim Holt Clinical Lecturer Centre for Primary Health Care Studies Warwick Medical School, UK

The cost-effectiveness of providing a DAFNE follow- up intervention to predicted non-responders J Kruger 1, A Brennan 1, P Thokala 1, S Heller 2 on behalf.

Clinical Validation of a Model-based Glycaemic Control Design Approach and Comparison to Other Clinical Protocols J.G. Chase et al Dept of Mechanical Engineering.

Highly Correlated Measures of Insulin Sensitivity Thomas Lotz 1, J Geoffrey Chase 1, Kirsten A McAuley 3, Jessica Lin 1, Geoffrey M Shaw 2, Chris E Hann.

We could know the results before the trial starts… JG Chase Centre for Bio-Engineering University of Canterbury New Zealand T Desaive Cardiovascular Research.

Sugar control in Critical care unit Senior clinical pharmacist : Lihua Fang Koo Foundation Cancer Center.

INTRODUCTION Stress-induced hyperglycaemia is common in critical care 1 Hyperglycaemia worsens patient outcomes, increasing risk of infection 2, myocardial.

Mr PS 76 years old COPD, no DM Severe CAP Day 1- intubated, sedated, high o2 requirements, vasopressor dependent Starting early EN Glucose 11.1 mmol/L.

The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.

Real-time control Model-Based Blood Glucose Control for Neonatal Intensive Care Engineering robust solutions for our most fragile infants Background and.

AJ Le Compte, CG Pretty, GM Shaw, JG Chase Introduction Elucidating links between glycemic control and clinical outcome requires reliable discrimination.

L.M. Fisk, A.J. Le Compte, G.M. Shaw, S. Penning, T. Desaive, J.G. Chase Pilot Trial of STAR in Medical ICU INTRODUCTION Background: Accurate glycemic.

Hyperglycemia-Am I A Control Freak? COPYRIGHT © 2013, ALL RIGHTS RESERVED From the Publishers of.

© Copyright 2009 by the American Association for Clinical Chemistry Glucose Meter Performance Criteria for Tight Glycemic Control Estimated by Simulation.

INTEGRAL-BASED IDENTIFICATION OF A PHYSIOLOGICAL INSULIN AND GLUCOSE MODEL ON EUGLYCAEMIC CLAMP AND IVGTT TRIALS T Lotz 1, J G Chase 1, K A McAuley 2,

TEMPLATE DESIGN © The impact of MC error (with and without shown): Figure 5: A sample fit comparison with and without.

HSRU is funded by the Chief Scientist Office of the Scottish Government Health Directorates. The author accepts full responsibility for this talk. Health.

A HIGHLY CORRELATED METHOD TO ASSESS INSULIN RESISTANCE IN BROAD POPULATIONS T Lotz 1 J G Chase 1, KA McAuley 2, GM Shaw 3, CE Hann 1, JI Mann 2 1 Department.

Introduction Clinical Setting - Glucoregulatory system - Patients and Data Assessment Proc. - Glucose sensors - Glycemia control system Control System.

Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.

EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.

Achieving Glycemic Control in the Hospital Setting Part 4 of 4.

Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.

Tight Glucose Control in Critically Ill Patients Using a Specialized Insulin- Nutrition Table Development Implementation of the SPRINT Protocol T. Lonergan,

Diagnosing cardiac disease states using a minimal cardiovascular model Christina Starfinger Wednesday, 21 March 2007 HRSC Scientific Meeting.

GRADE for reducing adverse outcomes actions to reduce adverse outcomes should be based on confidence in estimates of effectactions to reduce adverse outcomes.

PowerHour Information 03/09/2011.  Background  Description  Vision  Mission  Measurements  Participation Requirements.

Long Term Verification of Glucose-Insulin Regulatory System Model Dynamics THE 26th ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE.

South Asian Clinical Toxicology Research Collaboration Relative toxicity of pesticides in the developing world A Dawson, M Fahim, I Gawarammana, N Buckley,

Postoperative Glucose Control and SCIP Measures Gorav Ailawadi, MD Chief, Adult Cardiac Surgery University of Virginia April 25, 2015.

Prognostic models in the ICU From development to clinical practice L. Minne, MSc. Dr. S. Eslami, PharmD Dr. D.A. Dongelmans, MD Prof. Dr. S.E.J.A. de Rooij,

Achieving Glycemic Control in the Hospital Setting Part 1 of 3

Optimising Ventilation Using a Simple Model of Ventilated ARDS Lung Geoffrey M Shaw 1, J. Geoffrey Chase 2, Toshinori Yuta 2, Beverley Horn 2 and Christopher.

ABSTRACT Hyperglycaemia is prevalent in critical care, and tight control reduces mortality. Targeted glycaemic control can be achieved by frequent fitting.

Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Jabre et al. Lancet 2009;

14th IFAC (International Federation of Automatic Control) Symposium on System Identification, SYSID 2006, March IMPACT OF SYSTEM IDENTIFICATION METHODS.

 In a world full of processed sugars and fast food dollar menus, it is no wonder “more than 1 in 10 health care dollars in the U.S. are spent directly.

DERIVATIVE WEIGHTED ACTIVE INSULIN CONTROL ALGORITHMS AND TRIALS J. Geoffrey Chase, Geoffrey M. Shaw, Carmen V. Doran, Nicolas H. Hudson and Katherine.

Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)

Safety of Albumin Revisited Blood Products Advisory Committee Meeting March 17, 2005 Laurence Landow MD, FRCPC.

C. Pretty, A. Le Compte, J. G. Chase, G. Shaw, S. Penning, J-C Preiser, T. Desaive Introduction  Insulin sensitivity defines the metabolic balance between.

Achieving Glycemic Control in the Hospital Setting

Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.

A FULLY IDENTIFIABLE PHYSIOLOGICAL MODEL OF INSULIN KINETICS FOR CLINICAL APPLICATIONS T Lotz 1, J G Chase 1, S Andreassen 2, C E Hann 1, J Lin 1, J Wong.

Proposals by Paramedical Staff to Initiate Rehabilitation in Patients with Critical Illness on Mechanical Ventilation Acknowledgements This study was approved.

Update in Critical Care Medicine Ann Intern Med 2007;147:

Identification of Patient Specific Parameters for a Minimal Cardiac Model THE 26th ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE.

Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit Greet Hermans, Alexander.

Impact Of Intensity Of Glucose Control On Lactate Levels In Children After Cardiac Surgery Fule BK1, Kanthimathinathan HK3 Gan CS1, Davies P2, Laker S1,

Use of an intravascular continuous blood glucose sensor during post operative icu care of cardiac surgery patients K. Prasada, P. Gopalb, B. Cranec, A.

Tight Blood Glucose Control With Insulin in the ICU

Quality of Life Assessment

Evaluating The Accuracy Of International Classification Of Diseases 10TH Revision Codes For Venous Thromboembolism (VTE) And Major Bleeding (MB) in.

Evaluation of a plasma Insulin Model for Glycaemic Control in Intensive Care Jennifer Dickson, Felicity Thomas, Chris Pretty, Kent Stewart, Geoffrey Shaw,

Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock Dellinger RP, Levy MM, Rhodes A, Annane D, Carcillo JA, Gerlach.

Respiratory System Elastance Monitoring during PEEP Titration

Managing Hypoglycemia & Hyperglycemia

MetaVision® Suite: Value on Investment

Presentation transcript:

Validation of a Virtual Patient and Virtual Trials Method for Accurate Prediction of TGC Protocol Performance F Suhaimi 1,5, A.J. LeCompte 1, S Penning 4, C.G. Pretty 1, J.C. Preiser 4, T Desaive 4, G.M.Shaw 2,3 and J.G.Chase 1 1.Centre for Bioengineering, Department of Mechanical Engineering, University of Canterbury 2.Department of Intensive Care Medicine, Christchurch Hospital, New Zealand 3. Christchurch School of Medicine and Health Sciences, University of Otago, New Zealand 4. Dept of Intensive Care, Centre Hospitalier Universitaire de Liege (CHU), Liege, Belgium 5. Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia INTRODUCTION OVERVIEW: Tight glucose control (TGC) reduced intensive care unit (ICU) patient mortality up to 45% using a target of 6.1 mmol/L. TGC also reduce organ failure rate, severity and cost. “Virtual trials” are performed using a clinically validated model of the glucose-insulin system. Insulin sensitivity, S I, is used as the critical marker of a patient’s metabolic state and is assumed independent of the model inputs. Virtual trials can be used to simulate a TGC protocol using a S I profile identified from clinical data and different insulin and nutrition inputs. Virtual patient trials have been used in design of TGC protocols. The clinical results of SPRINT showed very close agreement to expected results from simulation. The performance of virtual trials on separate cohorts, independent of the ICU used to generate the virtual patients, has not yet been performed. GOALS: This study provides a source of independent, matched patient data for two groups treated with different TGC protocols. Patients in the Glucontrol study were randomised into two, matched cohorts with different glycemic protocols and targets. Only data from one Glucontrol centre (University Hospital of Liege, Belgium) was used. Virtual trial simulations are used to assess model errors and validate the overall virtual trials approach. VIRTUAL TRIALS METHOD Glucose-Insulin System Model SELF & CROSS VALIDATION SELF VALIDATION: Assess the ability of in-silico virtual trials to reproduce the clinical data. Differences of simulation results to clinical results are due to model errors and/or lack of perfect compliance. CROSS VALIDATION: Test the assumption that the SI profiles accurately capture patient dynamics, independent of the insulin and nutrition inputs used to create them. The patients in simulation will receive very different amounts of insulin compared to what was given clinically. Both cohorts are matched clinically, differences can be ascribed to the independence assumption behind this virtual trials method. CLINICAL DATA 211 patients were treated using the Glucontrol protocol at CHU de Liege, Belgium, between March 2004 and April Patients were randomly divided into two groups: o Group A – Glucontrol A protocol. o Group B – Glucontrol B protocol. RESULTS & DISCUSSION CDFs of Blood Glucose levels for clinical Glucontrol data and virtual trials on a (whole cohort basis) Clear separation in clinical BG results between Glucontrol A and Glucontrol B indicates difference in protocol behaviour. Self-validation and cross-validation results closely match clinical results for both Groups A and B. Cross validation result lies between the clinical data and self validation result indicating it is within the model and/or compliance error compared to the clinical data. Overall, simulation results reproduce clinical results using any collection of matched virtual patients. Wider error below 8 mmol/L is due to the fact that the Glucontrol B protocol requires zero exogenous insulin below its target. Gap between the self validation and clinical data indicates the possibility of compliance error whereas the difference between self validation may be model error, but may also suggest that lower intensity Group B protocol may not have been followed as strictly. CDFs of Blood Glucose levels for clinical Glucontrol data and virtual trials on a (per-patient basis) CONCLUSIONS Self Validation indicates a clinically insignificant error in these virtual patient methods due to model and/or clinical compliance. Cross Validation clearly shows the virtual patients enabled by the identified patient-specific SI(t) profiles are independent of the clinical inputs used to generate these profiles. These outcomes validate the ability of the virtual patients and in silico virtual trial methods presented to accurately simulate, in advance, the clinical results of an independent TGC protocol, directly enabling rapid design and optimisation of safe and effective TGC protocols with high confidence of clinical success. REFERENCES [1] G. Van den Berghe, et al., "Intensive insulin therapy in the critically ill patients," N Engl J Med, vol. 345, pp , Nov [2] J. G. Chase, et al., "Model-based insulin and nutrition administration for tight glycaemic control in critical care," Curr Drug Deliv, vol. 4, pp , Oct 2007.